140 related articles for article (PubMed ID: 6835062)
1. [Mathematical model of normal tissue involvement in gamma teletherapy].
Belov SA; Liass FM; Mamin RG; Minakova EI; Raevskaia SA
Med Radiol (Mosk); 1983 Mar; 28(3):75-80. PubMed ID: 6835062
[TBL] [Abstract][Full Text] [Related]
2. [The characteristics of managing cancer patients during gamma teletherapy].
Vorob'ev IuI
Med Radiol (Mosk); 1991; 36(12):38-40. PubMed ID: 1749332
[TBL] [Abstract][Full Text] [Related]
3. [The TDF model of the teletherapy of malignant tumors using fast neutrons].
Lisin VA
Med Radiol (Mosk); 1988 Sep; 33(9):9-12. PubMed ID: 3419305
[TBL] [Abstract][Full Text] [Related]
4. [Possibilities and limitations of isoeffective models in the assessment of the equivalence of courses of fractionated irradiation].
Akimov AA; Kozlov AP
Med Radiol (Mosk); 1991; 36(9):14-9. PubMed ID: 1943578
[TBL] [Abstract][Full Text] [Related]
5. Some aspects of the chronological dose distribution in the radiobiology and radiotherapy.
Ulmer W
Strahlenther Onkol; 1986 Jun; 162(6):374-86. PubMed ID: 3738738
[TBL] [Abstract][Full Text] [Related]
6. [Different fractionation regimens in the gamma teletherapy of rectal cancer].
Sarkisian IuKh; Antonova AM; Agafonova GB; Demidova LA
Med Radiol (Mosk); 1982 Jan; 27(1):55-8. PubMed ID: 7057696
[No Abstract] [Full Text] [Related]
7. [Treatment effectiveness and the radiation complications in patients with inoperable esophageal cancer undergoing rotation gamma therapy by open field and through a grid].
Sarkisian IuKh; Antonova AM; Kallistova LP; Pavlova TG
Med Radiol (Mosk); 1980 Jun; 25(6):44-51. PubMed ID: 7392834
[No Abstract] [Full Text] [Related]
8. [Gamma teletherapy of esophageal cancer using moving and static split-course methods].
Sarkisian IuKh; Antonova AM; Kallistova LP; Pavlova TG
Med Radiol (Mosk); 1981 Apr; 26(4):21-4. PubMed ID: 7231060
[No Abstract] [Full Text] [Related]
9. [Pathogenesis of postradiation hemorrhage in the combined treatment of bladder cancer].
Popov AI
Urol Nefrol (Mosk); 1984; (4):31-3. PubMed ID: 6474625
[No Abstract] [Full Text] [Related]
10. [Correction to Blair's model for the case of protracted continuous gamma irradiation of mice at a constant dosage rate].
Gusev OS
Radiobiologiia; 1980; 20(3):355-60. PubMed ID: 7403473
[No Abstract] [Full Text] [Related]
11. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
Klepper LIa
Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.
Levegrün S; Hof H; Essig M; Schlegel W; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):796-808. PubMed ID: 15183483
[TBL] [Abstract][Full Text] [Related]
13. [Factors influencing the response of normal tissue to radiation].
Masuda K; Jingu K; Hayabuchi N; Miyoshi M; Hirata H
Gan No Rinsho; 1987 Oct; 33(13):1551-9. PubMed ID: 3694794
[TBL] [Abstract][Full Text] [Related]
14. [Factors affecting the radiation reactions of chest cavity organs in gamma teletherapy of esophageal cancer].
Sarkisian IuKh; Antonova AM; Kallistova LP; Klimenko AA; Pavlova TG
Med Radiol (Mosk); 1981 Jun; 26(6):30-5. PubMed ID: 7266282
[No Abstract] [Full Text] [Related]
15. [The time factor in radiogenic subcutaneous fibrosis (author's transl)].
Gauwerky F; Langheim F
Strahlentherapie; 1978 Sep; 154(9):608-16. PubMed ID: 684781
[No Abstract] [Full Text] [Related]
16. Reirradiation tolerance of the human brain.
Mayer R; Sminia P
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1350-60. PubMed ID: 18037587
[TBL] [Abstract][Full Text] [Related]
17. [Application of the NSD-concept for the ascertainment of tolerance doses in the region of the lung (author's transl)].
Herrmann Th; Voigtmann L; Ehrhardt M; Eberhardt HJ; Strietzel M
Strahlentherapie; 1979 Jan; 155(1):10-4. PubMed ID: 760269
[TBL] [Abstract][Full Text] [Related]
18. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
19. On the problem of the characterization of late effects by a linear-quadratic survival function. I. Theoretical and radiobiological aspects.
Ulmer W
Strahlenther Onkol; 1987 Aug; 163(8):544-51. PubMed ID: 3629469
[TBL] [Abstract][Full Text] [Related]
20. [Use of shielding blocks for field formation in gamma teletherapy].
Liutova NA; Karpova IA; Ratner TG; Filippiuk VV
Med Radiol (Mosk); 1984 Apr; 29(4):69-72. PubMed ID: 6717269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
